Home > Publications database > Goodbye flat lymphoma biology. > print |
001 | 303255 | ||
005 | 20250802114338.0 | ||
024 | 7 | _ | |a 10.1002/1873-3468.70114 |2 doi |
024 | 7 | _ | |a pmid:40741889 |2 pmid |
024 | 7 | _ | |a 0014-5793 |2 ISSN |
024 | 7 | _ | |a 1873-3468 |2 ISSN |
037 | _ | _ | |a DKFZ-2025-01600 |
041 | _ | _ | |a English |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Faria, Carla |b 0 |
245 | _ | _ | |a Goodbye flat lymphoma biology. |
260 | _ | _ | |a Chichester |c 2025 |b Wiley |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1754056281_19093 |2 PUB:(DE-HGF) |x Review Article |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
500 | _ | _ | |a #EA:B060# / epub |
520 | _ | _ | |a B-cell lymphomas grow in aggregates, closely interacting with specific physical elements and cellular environments. While 2D culture systems have long been the standard in the field, current methodologies aim to better replicate lymphoma biology and its microenvironment in 3D. Significant progress has been made since the first 3D lymphoma cell line culture was developed in 2012. Subsequent advances in both cell line and patient-derived systems have incorporated key physical and cellular microenvironmental components. This Review compiles the relevant 3D non-Hodgkin lymphoma models available, outlining their main features, strengths, and limitations. Additionally, we highlight the critical gaps that must be addressed to develop robust, multiplexed, patient-derived B-cell lymphoma systems, which can serve as reliable avatars alongside clinical trials and contribute to the principles of the 3Rs in animal research. Impact statement In the last few years new B-cell lymphoma 3D models have emerged, with a special emphasis on patient-derived models. These systems are fundamental tools for precision medicine. This review provides translational researchers and clinician scientists with an excellent overview of these novel tools with their strong and weak points. |
536 | _ | _ | |a 312 - Funktionelle und strukturelle Genomforschung (POF4-312) |0 G:(DE-HGF)POF4-312 |c POF4-312 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
650 | _ | 7 | |a diffuse large B‐cell lymphoma |2 Other |
650 | _ | 7 | |a follicular lymphoma |2 Other |
650 | _ | 7 | |a lymphoma‐on‐chip |2 Other |
650 | _ | 7 | |a mantle cell lymphoma |2 Other |
650 | _ | 7 | |a non‐Hodgkin lymphoma |2 Other |
650 | _ | 7 | |a patient‐derived lymphoma models |2 Other |
650 | _ | 7 | |a preclinical 3D models |2 Other |
700 | 1 | _ | |a Dobano-Lopez, Celia |0 P:(DE-He78)07639d1e213099020e35bd19f159a705 |b 1 |e First author |u dkfz |
700 | 1 | _ | |a Pérez-Galán, Patricia |0 0000-0003-3895-5024 |b 2 |
700 | 1 | _ | |a Bezombes, Christine |b 3 |
773 | _ | _ | |a 10.1002/1873-3468.70114 |g p. 1873-3468.70114 |0 PERI:(DE-600)1460391-3 |p nn |t FEBS letters |v nn |y 2025 |x 0014-5793 |
909 | C | O | |o oai:inrepo02.dkfz.de:303255 |p VDB |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-He78)07639d1e213099020e35bd19f159a705 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-312 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Funktionelle und strukturelle Genomforschung |x 0 |
914 | 1 | _ | |y 2025 |
915 | _ | _ | |a DEAL Wiley |0 StatID:(DE-HGF)3001 |2 StatID |d 2024-12-19 |w ger |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2024-12-19 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2024-12-19 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2024-12-19 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2024-12-19 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2024-12-19 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2024-12-19 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2024-12-19 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2024-12-19 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2024-12-19 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b FEBS LETT : 2022 |d 2024-12-19 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2024-12-19 |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2024-12-19 |
915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |d 2024-12-19 |
920 | 1 | _ | |0 I:(DE-He78)B060-20160331 |k B060 |l B060 Molekulare Genetik |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)B060-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|